Literature DB >> 31149136

SPONTANEOUS CONCEPTION AND TERM DELIVERY IN A WOMAN WITH UNCONTROLLED ACROMEGALY AND HYPOGONADOTROPIC HYPOGONADISM.

C Căpăþînă1,2, Ş Radian1,2, I Baciu1,2, A Ghinea1, D Deciu1, A Dumitraşcu1, V Ciubotaru3, C Poiană1,2.   

Abstract

BACKGROUND: Patients with acromegaly (caused by growth-hormone-secreting pituitary adenomas) are at increased risk of hypopituitarism, in particular hypogonadotropic hypogonadism, before and after multimodal therapy. In affected women of reproductive age, fertility is impaired and complex fertility treatments are needed to achieve conception. CASE
PRESENTATION: We present the case of a young woman with acromegaly caused by a GH-secreting macroadenoma with suprasellar and bilateral cavernous sinus extension; hypogonadotropic hypogonadism and secondary hypothyroidism were present from the initial evaluation. Neurosurgical intervention was repeatedly recommended but the patient refused it initially; also she was non-compliant to the medical treatment of acromegaly. Transsphenoidal tumor debulking with adjuvant gamma-knife radiotherapy was eventually performed. Following treatment persistent active acromegaly and hypogonadotropic hypogonadism were diagnosed. Under chronic estroprogestative replacement therapy, the patient conceived and delivered a full-term healthy newborn without any complications. Possible mechanisms are discussed.
CONCLUSIONS: Secondary hypogonadotropic hypogonadism in pituitary patients, even when considered permanent (after surgery and radiotherapy), can exceptionally allow spontaneous conception and normal course of pregnancy.

Entities:  

Keywords:  acromegaly; hypogonadotrophic hypogonadism; pregnancy; spontaneous conception

Year:  2016        PMID: 31149136      PMCID: PMC6535235          DOI: 10.4183/aeb.2016.481

Source DB:  PubMed          Journal:  Acta Endocrinol (Buchar)        ISSN: 1841-0987            Impact factor:   0.877


  24 in total

1.  Spontaneous pregnancy in a patient with Sheehan's syndrome.

Authors:  E Algün; H Ayakta; M Harman; C Topal; H Aksoy
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2003-10-10       Impact factor: 2.435

Review 2.  Evaluating strategies for improving ovarian response of the poor responder undergoing assisted reproductive techniques.

Authors:  E S Surrey; W B Schoolcraft
Journal:  Fertil Steril       Date:  2000-04       Impact factor: 7.329

3.  Hypogonadism in patients with acromegaly: data from the multi-centre acromegaly registry pilot study.

Authors:  L Katznelson; D Kleinberg; M L Vance; S Stavrou; K J Pulaski; D A Schoenfeld; D L Hayden; M E Wright; C J Woodburn; A Klibanski; S Stravou
Journal:  Clin Endocrinol (Oxf)       Date:  2001-02       Impact factor: 3.478

Review 4.  Medical therapy for acromegaly.

Authors:  C B Newman
Journal:  Endocrinol Metab Clin North Am       Date:  1999-03       Impact factor: 4.741

Review 5.  Estrogen actions in the ovary revisited.

Authors:  K L Britt; J K Findlay
Journal:  J Endocrinol       Date:  2002-11       Impact factor: 4.286

Review 6.  The hypothalamic-pituitary-adrenal axis in pregnancy: challenges in disease detection and treatment.

Authors:  John R Lindsay; Lynnette K Nieman
Journal:  Endocr Rev       Date:  2005-04-12       Impact factor: 19.871

7.  High risk pregnancies in hypopituitary women.

Authors:  Caroline E Overton; Colin J Davis; Christine West; Melanie C Davies; Gerard S Conway
Journal:  Hum Reprod       Date:  2002-06       Impact factor: 6.918

8.  [Pregnancy and delivery after traumatic panhypopituitarism].

Authors:  L Pilka; M Snajderová; D Rumpík; T Kaplanová; R Pilka
Journal:  Ceska Gynekol       Date:  2003-07

9.  The outcome of surgery in 668 patients with acromegaly using current criteria of biochemical 'cure'.

Authors:  Panagiotis Nomikos; Michael Buchfelder; Rudolf Fahlbusch
Journal:  Eur J Endocrinol       Date:  2005-03       Impact factor: 6.664

Review 10.  The prevalence of pituitary adenomas: a systematic review.

Authors:  Shereen Ezzat; Sylvia L Asa; William T Couldwell; Charles E Barr; William E Dodge; Mary Lee Vance; Ian E McCutcheon
Journal:  Cancer       Date:  2004-08-01       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.